Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.71
+0.08 (1.05%)
At close: Apr 28, 2026, 4:00 PM EDT
7.67
-0.04 (-0.52%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Gyre Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Gyre Therapeutics stock have an average target of 17, with a low estimate of 16 and a high estimate of 18. The average target predicts an increase of 120.49% from the current stock price of 7.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 10, 2025.
Analyst Ratings
The average analyst rating for Gyre Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|
| Strong Buy | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +107.52% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +133.46% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
139.77M
from 116.59M
Increased by 19.88%
Revenue Next Year
135.30M
from 139.77M
Decreased by -3.20%
EPS This Year
-0.33
from 0.02
EPS Next Year
-0.20
from -0.33
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 207.9M | 168.2M | ||||||
| Avg | 139.8M | 135.3M | ||||||
| Low | 100.0M | 103.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 78.3% | 20.3% | ||||||
| Avg | 19.9% | -3.2% | ||||||
| Low | -14.3% | -26.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.22 | -0.20 | |
| Avg | -0.33 | -0.20 | |
| Low | -0.41 | -0.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.